sharpbrains.com
AnthroTronix CEO Corinna Lathan to discuss 510(k) FDA clearance of its DANA neurocognitive test at 2014 SharpBrains Virtual Summit - SharpBrains
Hap­py to share that Dr. Lath­an, CEO of Anthro­Tron­ix, will dis­cuss the brand-new 510(k) FDA clear­ance of their DANA neu­rocog­ni­tive test at the 2014 Sharp­Brains Vir­tual Sum­mit (Octo­ber 28–30th), dur­ing the ses­sion Best prac­tices to assess and enhance brain func­tion via mobile devices and wear­ables. Dr. Corin­na Lath­an leads Anthro­Tronix, a bio­med­ical engi­neer­ing prod­uct devel­op­ment com­pany and…
SharpBrains